Nemolizumab
Nemolizumab (CIM331) is a humanized monoclonal antibody targeting the human interleukin-31 receptor A, inhibiting IL-31 binding and subsequent signal transduction. It is useful for studying atopic dermatitis with pruritus.
Product Specifications
CAS Number
1476039-58-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Interleukin
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1022852-01 0.02 mg (E-Coli)
Recombinant Marinomonas sp. Putative reductase Mmwyl1_2865 (Mmwyl1_2865)
Sign In for Pricing
View Details 
MBS1022852-02 0.02 mg (Yeast)
Recombinant Marinomonas sp. Putative reductase Mmwyl1_2865 (Mmwyl1_2865)
Sign In for Pricing
View Details MBS1022852-03 0.1 mg (E-Coli)
Recombinant Marinomonas sp. Putative reductase Mmwyl1_2865 (Mmwyl1_2865)
Sign In for Pricing
View Details